BIH cooperates with Startupbootcamp Digital Health Berlin

After a successful cooperation in 2017, the Berlin Institute of Health (BIH) is working together with the accelerator program Startupbootcamp Digital Health Berlin again this year. The program supports ten international start-ups annually. The aim is...

More

Startupbootcamp Digital Health Berlin announces the 2018 cohort!

Startupbootcamp announces 12 startups from 8 different countries invited to join the 2018 Digital Health accelerator program in Berlin

More

Antibodies reduce antibiotic-induced side effects in the lungs

Researchers from Charité – Universitätsmedizin Berlin have shown that antibiotics can increase the risk of some types of pneumonia by weakening the lung’s immune system. Findings suggest that this risk may be reduced through the administration of...

More

sphingotec is adding an advanced POC testing platform to portfolio

 

German diagnostics company sphingotec GmbH (Hennigsdorf) and Nexus Dx (San Diego) have combined their technology platforms to market sphingotec’s CE-marked acute biomarkers penKid® and bio-ADM® on Nexus’ market-validated POC testing immunoassay...

More

Charité and BIH develop digital data processing infrastructure

Charité – Universitätsmedizin Berlin and the Berlin Institute of Health (BIH) are pleased to announce that ‘The Virtual Brain’ neuroinformatics platform has joined the EU’s Flagship ‘Human Brain Project’. With financial support from the EU’s Horizon...

More

Leonidas Zervas Award 2018

 

The Leonidas Zervas Award is presented in commemoration of his outstanding contributions to peptide science. The award is given to the scientist who has made the most outstanding contributions to the chemistry, biochemistry and/or biology of...

More

CO.DON negotiates with Xintela on the establishment of a joint venture

 

On 5 July 2018, CO.DON AG has signed a letter of intent (LOI) with Xintela AB, Lund (Sweden), by which the two companies have agreed to start negotiations regarding the establishment of a joint venture for the development and commercialization of...

More

Breakthrough in genetic engineering: Emmanuelle Charpentier wins Kavli Prize

Emmanuelle Charpentier, director at the Max Planck Institute for Infection Biology in Berlin, is among the winners of the internationally renowned Kavli prize. She is honoured for her pioneering work in developing the CRISPR-Cas9 system, a...

More

ProBioGen and Pionyr Immunotherapeutics Initiate a Second Immuno-Oncology Contract Development and Manufacturing Project

ProBioGen AG, a premier service and technology provider for complex therapeutic glycoproteins, and Pionyr Immunotherapeutics, an immuno-oncology company which develops next generation antibody-based therapeutics that target the tumor...

More
Show more items